Access the full text.
Sign up today, get DeepDyve free for 14 days.
O. Ringdén, M. Remberger, K. Holmberg, Charlotta Edeskog, Marie Wikström, B. Eriksson, Sigrun Finnbogadottir, K. Fransson, Ruza Milovsavljevic, B. Omazic, P. Svenberg, J. Mattsson, B. Svahn (2013)
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19 2
T. Gooley, J. Chien, S. Pergam, S. Hingorani, M. Sorror, M. Boeckh, P. Martin, B. Sandmaier, K. Marr, F. Appelbaum, R. Storb, G. McDonald (2010)
Reduced mortality after allogeneic hematopoietic-cell transplantation.The New England journal of medicine, 363 22
B. Svahn, M. Remberger, K. Myrbäck, K. Holmberg, B. Eriksson, P. Hentschke, J. Aschan, L. Barkholt, O. Ringdén (2002)
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.Blood, 100 13
H. Einsele, G. Ehninger, H. Hebart, Wittkowski Km, U. Schuler, G. Jahn, P. Mackes, M. Herter, T. Klingebiel, J. Löffler, S. Wagner, C. Muller (1995)
Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation.Blood, 86 7
O Ringden, M Remberger, V Runde, M Bornhauser, IW Blau, N Basara (1999)
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantationBlood, 94
R. Storb, R. Prentice, E. Thomas, F. Appelbaum, H. Deeg, K. Doney, A. Fefer, B. Goodell, E. Mickelson, P. Stewart, K. Sullivan, R. Witherspoon (1983)
Factors associated with graft rejection after HLA‐identical marrow transplantation for aplastic anaemiaBritish Journal of Haematology, 55
O. Ringdén, M. Remberger, V. Runde, N. Basara, O. Basu, G. Ehninger (2016)
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation
P. Hoogerbrugge, O. Brouwer, P. Bordigoni, G. Cornu, P. Kapaun, J. Ortega, A. O'meara, G. Souillet, D. Frappaz, S. Blanche, Anne‐Marie Fischer, O. Ringdén (1995)
Allogeneic bone marrow transplantation for lysosomal storage diseasesThe Lancet, 345
O. Ringdén, M. Remberger, U. Persson, P. Ljungman, A. Aldener, E. Andström, J. Aschan, P. Bolme, G. Dahllöf, T. Dalianis (1995)
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.Bone marrow transplantation, 15 4
B. Svahn, M. Remberger, Mona Heijbel, E. Martell, Marie Wikström, B. Eriksson, Ruza Milovsavljevic, J. Mattsson, O. Ringdén (2008)
Case-Control Comparison of At-Home and Hospital Care for Allogeneic Hematopoietic Stem-Cell Transplantation: The Role of Oral NutritionTransplantation, 85
Svahn Bm, B. Bjurman, KE Myrbäck, J. Aschan, Olle Ringdén (2000)
Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trialBone Marrow Transplantation, 26
M. Schaffer, M. Schaffer, A. Aldener-Cannavá, A. Aldener-Cannavá, M. Remberger, O. Ringdén, O. Olerup, O. Olerup (2003)
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.Tissue antigens, 62 3
P. Skinhøj, N. Jacobsen, N. Høiby, V. Faber (1987)
Strict protective isolation in allogenic bone marrow transplantation: effect on infectious complications, fever and graft versus host disease.Scandinavian journal of infectious diseases, 19 1
S. Slavin, A. Nagler, E. Naparstek, Yossi Kapelushnik, M. Aker, G. Cividalli, G. Váradi, M. Kirschbaum, A. Ackerstein, S. Samuel, A. Amar, C. Brautbar, O. Ben‐Tal, A. Eldor, R. Or (1998)
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.Blood, 91 3
Thomas Ed, Buckner Cd, M. Banaji, R. Clift, A. Fefer, N. Flournoy, B. Goodell, R. Hickman, Lerner Kg, P. Neiman, G. Sale, J. Sanders, J. Singer, M. Stevens, R. Storb, P. Weiden (1977)
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.Blood, 49 4
M. Remberger, M. Ackefors, S. Berglund, O. Blennow, G. Dahllöf, A. Dlugosz, K. Garming-Legert, J. Gertow, B. Gustafsson, Moustapha Hassan, Z. Hassan, D. Hauzenberger, H. Hägglund, H. Karlsson, L. Klingspor, G. Kumlien, K. Blanc, P. Ljungman, M. Machaczka, Karl-Johan Malmberg, H. Marschall, J. Mattsson, R. Olsson, B. Omazic, D. Sairafi, M. Schaffer, B. Svahn, P. Svenberg, L. Swartling, A. Szakos, M. Uhlin, M. Uzunel, E. Watz, A. Wernerson, A. Wikman, A. Wikström, J. Winiarski, O. Ringdén (2011)
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17 11
R. Storb, R. Prentice, C. Buckner, R. Clift, F. Appelbaum, J. Deeg, K. Doney, J. Hansen, M. Mason, J. Sanders, J. Singer, K. Sullivan, R. Witherspoon, E. Thomas (1983)
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.The New England journal of medicine, 308 6
P. Weiden, N. Flournoy, E. Thomas, R. Prentice, A. Fefer, C. Buckner, R. Storb (1979)
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.The New England journal of medicine, 300 19
H. Glucksberg, R. Storb, A. Fefer, Buckner Cd, P. Neiman, R. Clift, Lerner Kg, Thomas Ed (1974)
CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,STransplantation, 18
O. Ringdén, M. Remberger, Johan Törlén, M. Engström, G. Fjaertoft, J. Mattsson, B. Svahn (2014)
Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospitalPediatric Transplantation, 18
PM Hoogerbrugge, OF Brouwer, P Bordigoni, O Ringden, P Kapaun, JJ Ortega (1995)
Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow TransplantationLancet, 345
H. Hebart, L. Klingspor, T. Klingebiel, J. Loeffler, J. Tollemar, P. Ljungman, H. Wandt, K. Schaefer-Eckart, H. Dornbusch, C. Meisner, C. Engel, N. Stenger, T. Mayer, O. Ringdén, H. Einsele (2009)
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCTBone Marrow Transplantation, 43
E. Fondell, John Axelsson, K. Franck, A. Ploner, M. Lekander, K. Bälter, H. Gaines (2011)
Short natural sleep is associated with higher T cell and lower NK cell activitiesBrain, Behavior, and Immunity, 25
Stephanie Lee, J. Klein, A. Barrett, O. Ringdén, J. Antin, J. Cahn, M. Carabasi, R. Gale, S. Giralt, G. Hale, O. Ilhan, P. McCarthy, G. Socié, L. Verdonck, D. Weisdorf, M. Horowitz (2002)
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.Blood, 100 2
S. Carlens, O. Ringdén, M. Remberger, B. Lönnqvist, H. Hägglund, S. Klaesson, J. Mattsson, B. Svahn, J. Winiarski, P. Ljungman, J. Aschan (1998)
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysisBone Marrow Transplantation, 22
Johan Törlén, O. Ringdén, K. Garming-Legert, P. Ljungman, J. Winiarski, K. Remes, M. Itälä-Remes, M. Remberger, J. Mattsson (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationHaematologica, 101
J. Sive, K. Ardeshna, S. Cheesman, F. Grange, S. Morris, Claire Nicholas, K. Peggs, P. Statham, A. Goldstone (2012)
Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experienceLeukemia & Lymphoma, 53
D. Bekkum, Roodenburg, P., Heidt, D. Waaij (1974)
Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora.Journal of the National Cancer Institute, 52 2
B. Svahn, O. Alvin, O. Ringdén, A Gardulf, M. Remberger (2006)
Costs of Allogeneic Hematopoietic Stem Cell TransplantationTransplantation, 82
L. Luznik, P. O'Donnell, H. Symons, Allen Chen, M. Leffell, M. Zahurak, Ted Gooley, S. Piantadosi, M. Kaup, R. Ambinder, C. Huff, W. Matsui, J. Bolaños-Meade, I. Borrello, Jonathan Powell, Elizabeth Harrington, Sandra Warnock, M. Flowers, R. Brodsky, B. Sandmaier, R. Storb, Richard Jones, E. Fuchs (2008)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 6
Dietrich Beelen, E. Haralambie, Heinrich Brandt, Linzenmeier, Karl-D. Muller, K. Quabeck, Herbert Sayer, Ullrich Graeven, Hossam Mahmoud, U. Schaefer (1992)
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.Blood, 80 10
B. Pauw, Thomas Walsh, J. Donnelly, David A. Stevens, John E. Edwards, T. Calandra, Peter Pappas, J. Maertens, O. Lortholary, Carol Kauffman, D. Denning, Thomas Patterson, G. Maschmeyer, J. Billé, W. Dismukes, R. Herbrecht, William Hope, C. Kibbler, B. Kullberg, K. Marr, P. Muñoz, F. Odds, J. Perfect, Á. Restrepo, M. Ruhnke, B. Segal, Jack Sobel, Tania Sorrell, C. Viscoli, J. Wingard, T. Zaoutis, John E. Bennett (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 12
John Horan, Brent Logan, Manza-A Agovi-Johnson, H. Lazarus, Andrea Bacigalupo, K. Ballen, C. Bredeson, M. Carabasi, Vikas Gupta, Gregory Hale, H. Khoury, M. Juckett, M. Litzow, R. Martino, P. McCarthy, Franklin Smith, J. Rizzo, M. Pasquini (2009)
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 7
B. Svahn, B. Bjurman, K. Myrbäck, J. Aschan, O. Ringdén (2004)
Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial.Presse medicale, 33 7
Buckner Cd, R. Clift, J. Sanders, J. Meyers, G. Counts, V. Farewell, Thomas Ed (1978)
Protective environment for marrow transplant recipients: a prospective study.Annals of internal medicine, 89 6
O. Ringdén, H. Karlsson, R. Olsson, B. Omazic, M. Uhlin (2009)
The allogeneic graft‐versus‐cancer effectBritish Journal of Haematology, 147
J. Gratama, T. Stijnen, H. Weiland, A. Hekker, G. Gast, F. Zwaan, T. Weijers, J. D'Amaro, T. The, J. Vossen (1987)
HERPES-VIRUS IMMUNITY AND ACUTE GRAFT-VERSUS-HOST DISEASEThe Lancet, 329
E. Kaplan, P. Meier (1958)
Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 53
B. Omazic, M. Remberger, L. Barkholt, G. Söderdahl, Z. Potácová, P. Wersäll, B. Ericzon, J. Mattsson, O. Ringdén (2016)
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22 4
P. Reddy, J. Ferrara (2003)
Immunobiology of acute graft-versus-host disease.Blood reviews, 17 4
J. Jones, R. Wilson, P. Bealmear (1971)
Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras.Radiation research, 45 3
S. Ciurea, Mei-Jie Zhang, A. Bacigalupo, A. Bashey, F. Appelbaum, O. Aljitawi, P. Armand, J. Antin, Junfang Chen, S. Devine, D. Fowler, L. Luznik, R. Nakamura, P. O'Donnell, M. Perales, S. Pingali, D. Porter, M. Riches, O. Ringdén, V. Rocha, R. Vij, D. Weisdorf, R. Champlin, M. Horowitz, E. Fuchs, M. Eapen (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.Blood, 126 8
Jakob Passweg, P. Rowlings, Kerry Atkinson, A. Barrett, RobertPeter Gale, A. Gratwohl, N. Jacobsen, J. Klein, P. Ljungman, James Russell, U. Schaefer, K. Sobocinski, Jaak Vossen, Mei-Jie Zhang, Mary Horowitz (1998)
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaBone Marrow Transplantation, 21
Parry Rh (1946)
Health centres of today; Bristol.The Lancet, 1
N. Schmitz, P. Dreger, M. Suttorp, E. Rohwedder, T. Haferlach, H. Löffler, A. Hunter, Nh Russell (1995)
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)Blood, 85 6
Lennart Boström, O. Ringdén, Berit Sundberg, Annika Linde, J. Tollemar, B. Nilsson (1988)
Pretransplant herpesvirus serology and acute graft-versus-host disease.Transplantation, 46 4
J. Russell, M. Poon, A. Jones, R. Woodman, B. Ruether (1992)
Allogeneic bone-marrow transplantation without protective isolation in adults with malignant diseaseThe Lancet, 339
R. Storb, H. Deeg, M. Pepe, F. Appelbaum, C. Anasetti, P. Beatty, W. Bensinger, R. Berenson, Buckner Cd, R. Clift (1989)
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.Blood, 73 6
O. Ringdén, T. Ruutu, M. Remberger, J. Nikoskelainen, L. Volin, L. Vindeløv, T. Parkkali, S. Lenhoff, B. Sallerfors, P. Ljungman (1994)
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.Blood, 83 9
U. Forslöw, O. Blennow, K. Leblanc, O. Ringdén, B. Gustafsson, J. Mattsson, M. Remberger (2012)
Treatment with mesenchymal stromal cells is a risk factor for pneumonia‐related death after allogeneic hematopoietic stem cell transplantationEuropean Journal of Haematology, 89
Svahn Bm, O. Ringdén, M. Remberger (2005)
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantationBone Marrow Transplantation, 36
Patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) were given the option to be treated at home during the pancytopenic phase. Daily visits by a nurse and phone calls from a physician from the unit were part of the protocol. During almost two decades, 252 patients with haematological malignancies and non-malignant disorders were included. Median age was 47 (range 0–72) years. Myeloablative conditioning was given to 102 patients and reduced intensity to 150. Donors were matched unrelated (n = 160), HLA-identical siblings (n = 71), or HLA-mismatched (n = 21). Cumulative incidence of acute graft-versus-host disease (GVHD) was 35% and that of chronic GVHD was 46%. Non-relapse mortality was 14% 10 years after HSCT. In patients with haematological malignancies (n = 229), the 10-year probability of relapse was 34%. No patients died at home. Overall survival was 59% and relapse-free survival was 50% after 10 years. We conclude that patients treated at home after HSCT have an encouraging long-term outcome.
International Journal of Hematology – Springer Journals
Published: Nov 15, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.